Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

July 03, 2023 5:07 (London Time)

Amarin

Youtube Subscribe

...

Sector: Biotechnology
Ticker: AMRN
Sentiment: -0.5631
MarketCap: 468,946,548.0
High: 1.24 Low: 1.14

Open: 1.14 Close: 1.19 Change: 0.05

Are you still looking for information about Amarin Stock? An AI summarized it for you.

The game is changing. There is a new strategy to evaluate Amarin fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amarin are: Amarin, Sarissa, completely, management, AMRN, attorney, contact, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Amarin Corporation plc engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for.

Today's Summary

Amarin (AMRN) appears to have found support after losing some value lately. Amarin recently acquired a completely revamped management. Sarissa Sarissa taking over Amarins ( NASDAQ: AMRN ) management.

Today's News

Amarin recently acquired a completely revamped management. Sarissa Sarissa taking over Amarins ( NASDAQ: AMRN ) management completely. Amarin lowered its full-year outlook for operating expenses. Amarin (AMRN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. Amarin described Sarissas published statement as inaccurate and misleading The Street.com 2 Momentum Trades Showing Worst to First Action. Amarin and Bellerophon Therapeutics have been compared to each other in the stock market. Amarin has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Bellerophophotries has lower revenue, but higher earnings. No proposed summons received; attorney has been contacted; attorney contacted. Proposed Summons filed by Terrence Scott. Amarin to Present at Cowens 43rd Annual Health Care Conference. Sarissa Capital Condemns Amarin Board for Frontrunning Results of Proxy Contest With Egregious Equity Grants to Executives.

Stock Profile

"Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Amarin? Investor spend a lot of time searching for information to make investment decisions in Amarin. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amarin are: Amarin, Sarissa, completely, management, AMRN, attorney, contact, and the most common words in the summary are: amarin, stock, hotel, rating, top, news, market, . One of the sentences in the summary was: Amarin (AMRN) appears to have found support after losing some value lately. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amarin #stock #hotel #rating #top #news #market.

Read more →

Related Results

...
December 29, 2023 0:44 (London Time)

Amarin

Amarin Corporation plc (NASDAQ:AMRN) is an American firm developing treatments for people with heart diseases. Amarins biggest hedge fund investor i…
Sector: Biotechnology
Ticker: AMRN
Sentiment: 0.0
MarketCap: 370,320,676.0
High: 0.92 Low: 0.88

Open: 0.89 Close: 0.9 Change: 0.01

Read more →
...
November 01, 2023 13:53 (London Time)

Amarin

Amarin reiterates its belief that current cash and investments and other assets are adequate to support continued operations, including European lau…
Sector: Biotechnology
Ticker: AMRN
Sentiment: 0.9571
MarketCap: 283,945,592.0
High: 0.7 Low: 0.65

Open: 0.68 Close: 0.68 Change: 0.0

Read more →
...
July 03, 2023 5:07 (London Time)

Amarin

Amarin (AMRN) appears to have found support after losing some value lately. Amarin recently acquired a completely revamped management. Sarissa Saris…
Sector: Biotechnology
Ticker: AMRN
Sentiment: -0.5631
MarketCap: 468,946,548.0
High: 1.24 Low: 1.14

Open: 1.14 Close: 1.19 Change: 0.05

Read more →
...
December 05, 2023 5:54 (London Time)

Amarin

Sarissa Capital Management says Amarin stock undervalued. Sarissa won seven board seats at Amarin (AMRN ) - known as the developer of fish-oil deriv…
Sector: Biotechnology
Ticker: AMRN
Sentiment: 0.9531
MarketCap: 288,254,021.0
High: 0.76 Low: 0.7

Open: 0.75 Close: 0.7 Change: -0.05

Read more →
...
September 12, 2023 22:21 (London Time)

Amarin

Amarin Corporation plc (AMRN) stock is up 3.96% while the S&P 500 is down -0.68% as of 10:40 AM on Wednesday, Sep 6. Amarin to Present at the 2023 C…
Sector: Biotechnology
Ticker: AMRN
Sentiment: 0.6486
MarketCap: 411,988,288.0
High: 1.03 Low: 1.0

Open: 1.0 Close: 1.02 Change: 0.02

Read more →